
Sign up to save your podcasts
Or


Drs. Pasquier and LeGrand join eBioMedicine to discuss their stepwise approach to unveil druggable cancer vulnerabilities and to fast-track the identification of synergistic combinations against glioblastoma.
Continue this conversation on social!
By The Lancet GroupDrs. Pasquier and LeGrand join eBioMedicine to discuss their stepwise approach to unveil druggable cancer vulnerabilities and to fast-track the identification of synergistic combinations against glioblastoma.
Continue this conversation on social!

22 Listeners

0 Listeners

0 Listeners

3 Listeners

1 Listeners

0 Listeners

1 Listeners

0 Listeners

0 Listeners

0 Listeners

1 Listeners

1 Listeners

1 Listeners

0 Listeners

0 Listeners

0 Listeners

0 Listeners

0 Listeners

0 Listeners